Drug Profile
Anidulafungin/voriconazole - Pfizer
Alternative Names: Eraxis Vfend combination; Voriconazole/anidulafunginLatest Information Update: 12 Nov 2012
Price :
$50
*
At a glance
- Originator Pfizer
- Class
- Mechanism of Action 14-alpha demethylase inhibitors; Glucan synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Aspergillosis
Most Recent Events
- 09 Aug 2012 Discontinued - Phase-III for Aspergillosis in Asia (IV/PO combination)
- 09 Aug 2012 Discontinued - Phase-III for Aspergillosis in Australia (IV/PO combination)
- 09 Aug 2012 Discontinued - Phase-III for Aspergillosis in Canada (IV/PO combination)